13F

Stock

Relmada Therapeutics, Inc.

RLMD · held by 2 managers

Reported value

$378.8K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$4.57K

Price effect on 2 books still in the name

Largest holder

$359.2K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC146K$359.2K$2.97KAdded$325.6K
Leonteq Securities AG8K$19.7K$1.6KAdded$1.6K

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.